Reticulocyte
EPTIS factsheet 580221 | Last revision 2020-12-01 | URL: https://www.eptis.bam.de/pts580221 https://www.eptis.bam.de/pts580221
| PT provider | ||||||||||
| PT provider | RCPAQAP RCPAQAP | |||||||||
| Based in | Australia | |||||||||
| Language(s) | English | |||||||||
| Remarks | There are different options for this course, Please select from the below or contact us if you can't find the right device. Option 1 Manual Reticulocyte counting |Option 2: Beckman Coulter (STKS, MAXM, HmX) ; Sysmex Corporation: XT2000i, XE2100, XE5000, XT4000i, XN10); Abbott (Cell Dyn 3200/Ruby, 3500, 3700, 4000/Sapphire; Siemens ADVIA| Option 3: Beckman Coulter (Gen.S, LH500, LH750, LH755 & UniCell DxH 800) | |||||||||
| Keywords | ||||||||||
| Product groups |
Human test material
|
|||||||||
| Testing fields |
Medical analysis
|
|||||||||
| Technical details | ||||||||||
|
||||||||||
| Aims of the PT scheme | ||||||||||
| Target group of participants | ||||||||||
| Linked to specific legislation / standards | ||||||||||
| Additional, subsidiary aims | ||||||||||
| Number of participants | ||||||||||
| Accredited or otherwise reviewed by a 3rd party |
Accredited by NATA on the basis of Accredited by NATA on the basis of Accredited by NATA on the basis of ISO/IEC 17043: 2010 |
|||||||||
| Operation is commissioned / requested by | ||||||||||
| Fees and frequency | ||||||||||
| Participation fee | Yes | |||||||||
| Regularly operated | Yes (2 samples per survey/6 surveys) | |||||||||
| Year of first operation | ||||||||||
| Contact details of the PT provider | ||||||||||
| Provider | Contact person | |||||||||
|
RCPAQAP
Suite 201/8 Herbert Street St Leonards, 2065 Australia Phone: (61 2) 9045 6000 Fax: (61 2) 9356 2003 Web: https://www.rcpaqap.com.au/ https://www.rcpaqap.com.au/ |
Mr Rhys Judd
Phone: (61 2) 9045 6000 Fax: (61 2) 9356 2003 Email: rhys.judd@rcpaqap.com.au rhys.judd@rcpaqap.com.au |
|||||||||
If you find any mistakes please contact the responsible EPTIS coordinator in Australia,
Ms Luminita Antin.
Ms Luminita Antin.